Results 11 to 20 of about 4,899 (211)

TRPC5 in cardiovascular diseases [PDF]

open access: yesReviews in Cardiovascular Medicine, 2021
Cardiovascular diseases (CVD), especially acute myocardial infarction, are the leading cause of death, morbidity and disability across the world, affecting millions of people each year. Atherosclerosis (AS) is the major cause of CVD, and is a chronic
Sheng-Li Du   +3 more
doaj   +3 more sources

TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia [PDF]

open access: yesThe EMBO Journal
Hypoglycemia triggers autonomic and endocrine counter-regulatory responses to restore glucose homeostasis, a response that is impaired in patients with diabetes and its long-term complication hypoglycemia-associated autonomic failure (HAAF). We show that
Jenny Bröker-Lai   +39 more
doaj   +5 more sources

Plasma membrane mechanical stress activates TRPC5 channels. [PDF]

open access: yesPLoS ONE, 2015
Mechanical forces exerted on cells impose stress on the plasma membrane. Cells sense this stress and elicit a mechanoelectric transduction cascade that initiates compensatory mechanisms.
Bing Shen   +6 more
doaj   +4 more sources

Molecular architecture of the Gαi-bound TRPC5 ion channel

open access: yesNature Communications, 2023
G-protein coupled receptors (GPCRs) and ion channels serve as key molecular switches through which extracellular stimuli are transformed into intracellular effects, and it has long been postulated that ion channels are direct effector molecules of the ...
Jongdae Won   +10 more
doaj   +3 more sources

N-palmitoyl glycine differentially modulates TRPM4 and TRPC5 and is causally linked to Brugada syndrome [PDF]

open access: yesCommunications Biology
Brugada syndrome (BrS) is an inherited cardiac arrhythmic disorder associated with an increased risk of malignant ventricular arrhythmia and sudden death.
Hongxuan Xu   +5 more
doaj   +2 more sources

Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity [PDF]

open access: yesActa Pharmaceutica Sinica B
Recent advances in ion channel structural biology have enhanced structure-based drug design, yet lipid-occupied binding pockets—often large and flat—remain a major hurdle for developing selective small molecules.
Tong Che   +15 more
doaj   +2 more sources

TRPC5: a new entry to the chromaffin cell’s palette of ion channels that control adrenal response to hypoglycemia [PDF]

open access: yesThe EMBO Journal
Regulation of glucose levels during insulin-evoked hypoglycemia is impaired in patients with diabetes and can lead to a condition called hypoglycemia-associated autonomic failure (HAAF). The underlying mechanism of the reduced sympathoadrenal response in
Emilio Carbone
doaj   +2 more sources

Adriamycin-induced podocyte injury via the Sema3A/TRPC5/Rac1 pathway [PDF]

open access: yesFrontiers in Medicine
Podocytopathies encompass kidney diseases where direct or indirect podocyte injury leads to proteinuria or nephrotic syndrome. Although Semaphorin3A (Sema3A) is expressed in podocytes and tubular cells in adult mammalian kidneys and has a common effect ...
Yan Liu   +8 more
doaj   +2 more sources

BTDAzo - a photoswitchable TRPC5 channel activator [PDF]

open access: yesAngewandte Chemie, 2022
Photoswitchable reagents to modulate protein activity are powerful tools for high-spatiotemporal-precision control over endogenous biological functions. TRPC5 is a Ca2+-permeable cation channel with distinct tissue-specific roles, ranging from synaptic function to hormone regulation.
Markus Müller   +7 more
openaire   +3 more sources

TRPC5-eNOS Axis Negatively Regulates ATP-Induced Cardiomyocyte Hypertrophy [PDF]

open access: yesFrontiers in Pharmacology, 2018
Cardiac hypertrophy, induced by neurohumoral factors, including angiotensin II and endothelin-1, is a major predisposing factor for heart failure. These ligands can induce hypertrophic growth of neonatal rat cardiomyocytes (NRCMs) mainly through Ca2 ...
Caroline Sunggip   +15 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy